Elanco Animal Health INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Dimensional Fund Advisors LP has disclosed a beneficial ownership of 5.1% of Elanco Animal Health Inc.'s common stock as of June 30, 2026.
NYSE
Dodge & Cox has reported a beneficial ownership of 13.9% in Elanco Animal Health Incorporated as of March 31, 2026, holding 68,944,100 shares.
NYSE
PrimeCap Management Co/CA/ has reported a beneficial ownership of 9.22% in Elanco Animal Health Incorporated as of March 31, 2026.
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 5.25% beneficial ownership stake in Elanco Animal Health Inc.
NYSE
Dimensional Fund Advisors LP has disclosed a beneficial ownership of 4.9% of Elanco Animal Health Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Elanco Animal Health Inc. following an internal realignment.
NYSE
SCHEDULE: Dodge & Cox Boosts Elanco Stake to 15.9%
Dodge & Cox, an investment adviser, has reported a 15.9% beneficial ownership stake in Elanco Animal Health Incorporated's common stock.
NYSE
FMR LLC and Abigail P. Johnson have disclosed an increased beneficial ownership of 10.5% in Elanco Animal Health Inc., holding over 52 million common shares.
NYSE
Dimensional Fund Advisors LP has reported a 5.0% beneficial ownership stake in Elanco Animal Health Inc, holding over 25 million shares of common stock.
NYSE
T. Rowe Price Investment Management, Inc. has reported a 6.4% beneficial ownership stake in Elanco Animal Health Inc. common stock.
NYSE
SCHEDULE 13G: BlackRock Boosts Stake in Elanco Animal Health to 8.9%
BlackRock, Inc. has reported an 8.9% beneficial ownership stake in Elanco Animal Health Inc., holding over 44 million shares of common stock.
NYSE
FMR LLC and Abigail P. Johnson have reported a 13.1% beneficial ownership stake in Elanco Animal Health Inc., totaling over 64 million shares.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 4.4% passive beneficial ownership stake in Elanco Animal Health Inc. as of March 31, 2025.
NYSE
FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a combined beneficial ownership of 10.0% of Elanco Animal Health Inc.'s common stock as of February 28, 2025.
NYSE
SCHEDULE 13G: FMR LLC and Abigail P. Johnson Disclose 8.1% Passive Stake in Elanco Animal Health Inc.
FMR LLC and its affiliate Abigail P. Johnson have filed a Schedule 13G, reporting a passive beneficial ownership of 8.1% in Elanco Animal Health Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 5.0% of Elanco Animal Health Inc's common stock as of December 31, 2024.